跳至主要内容
临床试验/NCT07145554
NCT07145554已完成不适用

Comparative Effectiveness of Focal Extracorporeal Shock Wave Therapy and Steroid Injection in Piriformis Syndrome

Gulhane Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Pain intensity measured by Numeric Rating Scale (NRS)

研究概览

简要总结

This study aims to compare two treatment methods for piriformis syndrome, a condition that can cause pain in the buttock and leg. Adult patients with piriformis syndrome will take part in the trial. Participants will be randomly assigned to one of two groups. One group will receive focal extracorporeal shock wave therapy (f-ESWT), a non-invasive treatment that uses sound waves. The other group will receive a steroid injection, which is a common treatment used to reduce pain and inflammation. The goal of this study is to find out which treatment is more effective in improving symptoms of piriformis syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with piriformis syndrome whose pain has persisted for three months or longer despite standard medical care and activity modifications.

排除标准

  • •Individuals with lumbar discopathy diagnosed by magnetic resonance imaging or electrodiagnostic study.
  • •Patients with coccyx pain.
  • •Individuals with mechanical or inflammatory disorders of the sacroiliac joint.
  • •Patients with pelvic region diseases.
  • •Pregnancy
  • •History of previous lumbar disc surgery.
  • •History of lumbar epidural block within the last 6 months.
  • •History of malignancy.
  • •Patients with signs of acute inflammation at the treatment site.
  • •Individuals with a cardiac pacemaker.

研究组 & 干预措施

Injection group

Experimental

干预措施: Steroid Injection (Procedure)

Shock wave group

Experimental

干预措施: Focal extracorporeal schock wave therapy (Other)

结局指标

主要结局

Pain intensity measured by Numeric Rating Scale (NRS)

时间窗: Baseline, 1 week, 4 weeks, and 12 weeks post-treatment

Quality of life measured by SF-36 questionnaire

时间窗: Baseline and 4 weeks post-treatment

次要结局

未报告次要终点

研究者

发起方
Gulhane Training and Research Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Hilal Busra Aycicek

MD, Specialist in Physical Medicine and Rehabilitation

Gulhane Training and Research Hospital

研究点 (1)

Loading locations...

相似试验

f-ESWT vs Steroid Injection for Piriformis Syndrome | 临床试验